Top

27-09-2024 | Nephrotic Syndrome | Review

Nucleoporin-associated steroid-resistant nephrotic syndrome

Authors: Ling Yao, Yuanyuan Li, Ping Wang, Chan Xu, Zihua Yu

Abstract

Nucleoporins (Nups) are a class of proteins that assemble to form nuclear pore complexes, which are related to nucleocytoplasmic transport, gene expression, and the cell cycle. Pathogenic variants in six genes encoding Nups, NUP85, NUP93, NUP107, NUP133, NUP160, and NUP205, cause monogenic steroid-resistant nephrotic syndrome (SRNS), referred to as nucleoporin-associated SRNS. In this paper, we review the epidemiology, structure and function of Nups, pathogenesis, phenotypes and genotypes, and management of nucleoporin-associated SRNS as well as implications for genetic counseling. Affected individuals exhibit autosomal recessive isolated and syndromic SRNS, whose extrarenal manifestations include neurological disorders, growth and development disorders, cardiovascular disorders, and congenital malformations. The median ages at onset of NUP85-, NUP93-, NUP107-, NUP133-, NUP160-, and NUP205-associated SRNS are 7, 3, 4.1, 9, 7, and 2 years, respectively. Kidney biopsies reveal focal segmental glomerulosclerosis in 89% of patients. Most affected individuals are resistant to immunosuppressants. For the six subtypes of nucleoporin-associated SRNS, patients show progression to kidney failure at median ages of 8.5, 3.7, 6.9, 13, 15, and 7 years, respectively. Only two patients with NUP93-associated SRNS with nephrotic syndrome relapse post-transplant have been reported, and the recurrence rate is 12.5%. Next-generation sequencing using a targeted gene panel is recommended in cases of suspected nucleoporin-associated SRNS for genetic diagnosis. Renin–angiotensin–aldosterone system inhibitors are recommended for patients with nucleoporin-associated SRNS. Once genetic diagnosis is confirmed, immunosuppressant discontinuation should be considered, and kidney transplant is preferred when patients progress to kidney failure. Genetic counselling should be provided for asymptomatic siblings and future siblings of an affected individual. Further studies on the pathogenesis of nucleoporin-associated SRNS are needed to seek new therapeutic interventions.

Noone DG, Iijima K, Parekh R (2018) Idiopathic nephrotic syndrome in children. Lancet 392:61–74. https://doi.org/10.1016/s0140-6736(18)30536-1CrossRefPubMed

Zhao F, Zhu JY, Richman A, Fu Y, Huang W, Chen N, Pan X, Yi C, Ding X, Wang S, Wang P, Nie X, Huang J, Yang Y, Yu Z, Han Z (2019) Mutations in NUP160 are implicated in steroid-resistant nephrotic syndrome. J Am Soc Nephrol 30:840–853. https://doi.org/10.1681/asn.2018080786CrossRefPubMedPubMedCentral

Li Y, Yao L, Yu Z (2024) Mutations in NUP160 cause steroid-resistant nephrotic syndrome. Pediatr Nephrol 39:2263–2265. https://doi.org/10.1007/s00467-024-06313-9CrossRefPubMed

Wiggins RC (2007) The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int 71:1205–1214. https://doi.org/10.1038/sj.ki.5002222CrossRefPubMed

Kopp JB, Anders HJ, Susztak K, Podesta MA, Remuzzi G, Hildebrandt F, Romagnani P (2020) Podocytopathies. Nat Rev Dis Primers 6:68. https://doi.org/10.1038/s41572-020-0196-7CrossRefPubMedPubMedCentral

Park JSR, Qiu C, Kondo A, Huang S, Werth M, Li M, Barasch J, Suszták K (2018) Single-cell transcriptomics of the mouse kidney reveals potential cellular targets of kidney disease. Science 360:758–763. https://doi.org/10.1126/science.aar2131CrossRefPubMedPubMedCentral

Malaga-Dieguez L, Susztak K (2013) ADCK4 “reenergizes” nephrotic syndrome. J Clin Invest 123:4996–4999. https://doi.org/10.1172/JCI73168CrossRefPubMedPubMedCentral

Miyake N, Tsukaguchi H, Koshimizu E, Shono A, Matsunaga S, Shiina M, Mimura Y, Imamura S, Hirose T, Okudela K, Nozu K, Akioka Y, Hattori M, Yoshikawa N, Kitamura A, Cheong HI, Kagami S, Yamashita M, Fujita A, Miyatake S, Tsurusaki Y, Nakashima M, Saitsu H, Ohashi K, Imamoto N, Ryo A, Ogata K, Iijima K, Matsumoto N (2015) Biallelic mutations in nuclear pore complex subunit NUP107 cause early-childhood-onset steroid-resistant nephrotic syndrome. Am J Hum Genet 97:555–566. https://doi.org/10.1016/j.ajhg.2015.08.013CrossRefPubMedPubMedCentral

Rosti RO, Sotak BN, Bielas SL, Bhat G, Silhavy JL, Aslanger AD, Altunoglu U, Bilge I, Tasdemir M, Yzaguirrem AD, Musaev D, Infante S, Thuong W, Marin-Valencia I, Nelson SF, Kayserili H, Gleeson JG (2017) Homozygous mutation in NUP107 leads to microcephaly with steroid-resistant nephrotic condition similar to Galloway-Mowat syndrome. J Med Genet 54:399–403. https://doi.org/10.1136/jmedgenet-2016-104237CrossRefPubMed

10.

Braun DA, Lovric S, Schapiro D, Schneider R, Marquez J, Asif M, Hussain MS, Daga A, Widmeier E, Rao J, Ashraf S, Tan W, Lusk CP, Kolb A, Jobst-Schwan T, Schmidt JM, Hoogstraten CA, Eddy K, Kitzler TM, Shril S, Moawia A, Schrage K, Khayyat AIA, Lawson JA, Gee HY, Warejko JK, Hermle T, Majmundar AJ, Hugo H, Budde B, Motameny S, Altmüller J, Noegel AA, Fathy HM, Gale DP, Waseem SS, Khan A, Kerecuk L, Hashmi S, Mohebbi N, Ettenger R, Serdaroğlu E, Alhasan KA, Hashem M, Goncalves S, Ariceta G, Ubetagoyena M, Antonin W, Baig SM, Alkuraya FS, Shen Q, Xu H, Antignac C, Lifton RP, Mane S, Nürnberg P, Khokha MK, Hildebrandt F (2018) Mutations in multiple components of the nuclear pore complex cause nephrotic syndrome. J Clin Invest 128:4313–4328. https://doi.org/10.1172/JCI98688CrossRefPubMedPubMedCentral

11.

Braun DA, Sadowski CE, Kohl S, Lovric S, Astrinidis SA, Pabst WL, Gee HY, Ashraf S, Lawson JA, Shril S, Airik M, Tan W, Schapiro D, Rao J, Choi WI, Hermle T, Kemper MJ, Pohl M, Ozaltin F, Konrad M, Bogdanovic R, Buscher R, Helmchen U, Serdaroglu E, Lifton RP, Antonin W, Hildebrandt F (2016) Mutations in nuclear pore genes NUP93, NUP205 and XPO5 cause steroid-resistant nephrotic syndrome. Nat Genet 48:457–465. https://doi.org/10.1038/ng.3512CrossRefPubMedPubMedCentral

12.

Fujita A, Tsukaguchi H, Koshimizu E, Nakazato H, Itoh K, Kuraoka S, Komohara Y, Shiina M, Nakamura S, Kitajima M, Tsurusaki Y, Miyatake S, Ogata K, Iijima K, Matsumoto N, Miyake N (2018) Homozygous splicing mutation in NUP133 causes Galloway-Mowat syndrome. Ann Neurol 84:814–828. https://doi.org/10.1002/ana.25370CrossRefPubMed

13.

Wang P, Zhao F, Nie X, Liu J, Yu Z (2018) Knockdown of NUP160 inhibits cell proliferation, induces apoptosis, autophagy and cell migration, and alters the expression and localization of podocyte associated molecules in mouse podocytes. Gene 664:12–21. https://doi.org/10.1016/j.gene.2018.04.067CrossRefPubMed

14.

Li Y, Xu C, Zhao F, Liu Q, Qiu X, Li M, Yang Y, Yu S, Tong H, Zhang L, Chen B, Qu L, Yu Z (2024) Podocyte-specific Nup160 knockout mice develop nephrotic syndrome and glomerulosclerosis. Hum Mol Genet 33:667–676. https://doi.org/10.1093/hmg/ddad211CrossRefPubMed

15.

Maddirevula S, Shamseldin HE, Sirr A, AlAbdi L, Lo RS, Ewida N, Al-Qahtani M, Hashem M, Abdulwahab F, Aboyousef O, Kaya N, Monies D, Salem MH, Al Harbi N, Aldhalaan HM, Alzaidan H, Almanea HM, Alsalamah AK, Al Mutairi F, Ismail S, Abdel-Salam GMH, Alhashem A, Asery A, Faqeih E, AlQassmi A, Al-Hamoudi W, Algoufi T, Shagrani M, Dudley AM, Alkuraya FS (2020) Exploiting the autozygome to support previously published Mendelian gene-disease associations: an update. Front Genet 11:580484. https://doi.org/10.3389/fgene.2020.580484CrossRefPubMedPubMedCentral

16.

Lipska-Zietkiewicz BS, Schaefer F (2019) NUP nephropathy: when defective pores cause leaky glomeruli. Am J Kidney Dis 73:890–892. https://doi.org/10.1053/j.ajkd.2019.01.015CrossRefPubMed

17.

Seeman T, Vondrak K (2018) First report of recurrent nephrotic syndrome after kidney transplantation in a patient with NUP93 gene mutations: a case report. Transplant Proc 50:3954–3956. https://doi.org/10.1016/j.transproceed.2018.07.010CrossRefPubMed

18.

Bezdíčka M, Štolbová Š, Seeman T, Cinek O, Malina M, Šimánková N, Průhová Š, Zieg J (2018) Genetic diagnosis of steroid-resistant nephrotic syndrome in a longitudinal collection of Czech and Slovak patients: a high proportion of causative variants in NUP93. Pediatr Nephrol 33:1347–1363. https://doi.org/10.1007/s00467-018-3950-2CrossRefPubMed

19.

Cason RK, Williams A, Chryst-Stangl M, Wu G, Huggins K, Brathwaite KE, Lane BM, Greenbaum LA, D’Agati VD, Gbadegesin RA (2022) Collapsing focal segmental glomerulosclerosis in siblings with compound heterozygous variants in NUP93 expand the spectrum of kidney phenotypes associated with nucleoporin gene mutations. Front Pediatr 10:915174. https://doi.org/10.3389/fped.2022.915174CrossRefPubMedPubMedCentral

20.

Kuran P, Platos E, Mizerska-Wasiak M, Pańczyk-Tomaszewska M (2023) A rare cause of steroid-resistant nephrotic syndrome - a case report. Cent Eur J Immunol 48:158–162. https://doi.org/10.5114/ceji.2023.127534CrossRefPubMedPubMedCentral

21.

Park E, Ahn YH, Kang HG, Miyake N, Tsukaguchi H, Cheong HI (2017) NUP107 mutations in children with steroid-resistant nephrotic syndrome. Nephrol Dial Transplant 32:1013–1017. https://doi.org/10.1093/ndt/gfw103CrossRefPubMed

22.

Park E, Lee C, Kim NKD, Ahn YH, Park YS, Lee JH, Kim SH, Cho MH, Cho H, Yoo KH, Shin JI, Kang HG, Ha IS, Park WY, Cheong HI (2020) Genetic study in Korean pediatric patients with steroid-resistant nephrotic syndrome or focal segmental glomerulosclerosis. J Clin Med 9:2013. https://doi.org/10.3390/jcm9062013CrossRefPubMedPubMedCentral

23.

Bierzynska A, McCarthy HJ, Soderquest K, Sen ES, Colby E, Ding WY, Nabhan MM, Kerecuk L, Hegde S, Hughes D, Marks S, Feather S, Jones C, Webb NJ, Ognjanovic M, Christian M, Gilbert RD, Sinha MD, Lord GM, Simpson M, Koziell AB, Welsh GI, Saleem MA (2017) Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management. Kidney Int 91:937–947. https://doi.org/10.1016/j.kint.2016.10.013CrossRefPubMed

24.

Kitamura A, Tsukaguchi H, Iijima K, Araki J, Hattori M, Ikeda M, Honda M, Nozu K, Nakazato H, Yoshikawa N, Kagami S, Muramatsu M, Choi Y, Cheong HI, Doi T (2006) Genetics and clinical features of 15 Asian families with steroid-resistant nephrotic syndrome. Nephrol Dial Transplant 21:3133–3138. https://doi.org/10.1093/ndt/gfl347CrossRefPubMed

25.

Han Y, Sha H, Yang Y, Yu Z, Zhou L, Wang Y, Yang F, Qiu L, Zhang Y, Zhou J (2024) Mutations in the NUP93, NUP107 and NUP160 genes cause steroid-resistant nephrotic syndrome in Chinese children. Ital J Pediatr 50:81. https://doi.org/10.1186/s13052-024-01656-3CrossRefPubMedPubMedCentral

26.

Wang Q, Gu R, Li FW, Gu WY, Zhang JJ (2023) Steroid-resistant nephrotic syndrome caused by nuclear pore gene NUP133 variation. Clin Genet 104:272–274. https://doi.org/10.1111/cge.14339CrossRefPubMed

27.

Najafi M, Riedhammer KM, Rad A, Torbati PN, Berutti R, Schüle I, Schroda S, Meitinger T, Ćomić J, Bojd SS, Baranzehi T, Shojaei A, Azarfar A, Khazaei MR, Köttgen A, Backofen R, Karimiani EG, Hoefele J, Schmidts M (2022) High detection rate for disease-causing variants in a cohort of 30 Iranian pediatric steroid resistant nephrotic syndrome cases. Front Pediatr 10:974840. https://doi.org/10.3389/fped.2022.974840CrossRefPubMedPubMedCentral

28.

Bierzynska A, Bull K, Miellet S, Dean P, Neal C, Colby E, McCarthy HJ, Hegde S, Sinha MD, Bugarin Diz C, Stirrups K, Megy K, Mapeta R, Penkett C, Marsh S, Forrester N, Afzal M, Stark H, BioResource N, Williams M, Welsh GI, Koziell AB, Hartley PS, Saleem MA (2022) Exploring the relevance of NUP93 variants in steroid-resistant nephrotic syndrome using next generation sequencing and a fly kidney model. Pediatr Nephrol 37:2643–2656. https://doi.org/10.1007/s00467-022-05440-5CrossRefPubMedPubMedCentral

29.

McCarthy HJ, Bierzynska A, Wherlock M, Ognjanovic M, Kerecuk L, Hegde S, Feather S, Gilbert RD, Krischock L, Jones C, Sinha MD, Webb NJ, Christian M, Williams MM, Marks S, Koziell A, Welsh GI, Saleem MA (2013) Simultaneous sequencing of 24 genes associated with steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol 8:637–648. https://doi.org/10.2215/CJN.07200712CrossRefPubMedPubMedCentral

30.

Dhanorkar MA, Rao SN, Malhotra KP, Ansari M, Chandra A (2023) Novel NUP93 gene variant and diffuse mesangial sclerosis in steroid resistant nephrotic syndrome. Indian J Pediatr 91:517–517. https://doi.org/10.1007/s12098-023-04887-0CrossRefPubMed

31.

Al Riyami MS, Al Alawi I, Al Gaithi B, Al Maskari A, Al Kalbani N, Al Hashmi N, Al Balushi A, Al Shahi M, Al Saidi S, Al Bimani M, Al Hatali F, Mabillard H, Sayer JA (2023) Genetic analysis and outcomes of Omani children with steroid-resistant nephrotic syndrome. Mol Genet Genomic Med 11:e2201. https://doi.org/10.1002/mgg3.2201CrossRefPubMedPubMedCentral

32.

Sandokji I, Marquez J, Ji W, Zerillo CA, Konstantino M, Lakhani SA, Khokha MK, Warejko JK (2019) Identification of novel mutations and phenotype in the steroid resistant nephrotic syndrome gene NUP93: a case report. BMC Nephrol 20:271. https://doi.org/10.1186/s12882-019-1458-zCrossRefPubMedPubMedCentral

33.

Zhao B, Chen JY, Liao YB, Li YF, Jiang XM, Bi X, Yang MF, Li L, Cui JJ (2021) Steroid-resistant nephrotic syndrome in infants caused by a novel compound heterozygous mutation of the NUP93: a CARE case report. Medicine 100:e24627. https://doi.org/10.1097/MD.0000000000024627CrossRefPubMedPubMedCentral

34.

Wasilewska A, Rybi-Szuminska A, Dubiela P (2023) Steroid-resistant nephrotic syndrome caused by NUP93 pathogenic variants. J Clin Med 12:5810. https://doi.org/10.3390/jcm12185810CrossRefPubMedPubMedCentral

35.

Rossanti R, Shono A, Miura K, Hattori M, Yamamura T, Nakanishi K, Minamikawa S, Fujimura J, Horinouchi T, Nagano C, Sakakibara N, Kaito H, Nagase H, Morisada N, Asanuma K, Matsuo M, Nozu K, Iijima K (2019) Molecular assay for an intronic variant in NUP93 that causes steroid resistant nephrotic syndrome. J Hum Genet 64:673–679. https://doi.org/10.1038/s10038-019-0606-4CrossRefPubMed

36.

Hashimoto T, Harita Y, Takizawa K, Urae S, Ishizuka K, Miura K, Horita S, Ogino D, Tamiya G, Ishida H, Mitsui T, Hayasaka K, Hattori M (2019) Invivo expression of NUP93 and its alteration by NUP93 mutations causing focal segmental glomerulosclerosis. Kidney Int Rep 4:1312–1322. https://doi.org/10.1016/j.ekir.2019.05.1157CrossRefPubMedPubMedCentral

37.

Gambadauro A, Mangano GD, Galletta K, Granata F, Riva A, Massella L, Guzzo I, Farello G, Scorrano G, Di Francesco L, Di Donato G, Ianni C, Di Ludovico A, La Bella S, Striano P, Efthymiou S, Houlden H, Nardello R, Chimenz R (2023) NUP85 as a neurodevelopmental gene: from podocyte to neuron. Genes 14:2143. https://doi.org/10.3390/genes14122143CrossRefPubMedPubMedCentral

38.

von Appen A, Beck M (2016) Structure determination of the nuclear pore complex with three-dimensional cryo electron microscopy. J Mol Biol 428:2001–2010. https://doi.org/10.1016/j.jmb.2016.01.004CrossRef

39.

Chug H, Trakhanov S, Hülsmann BB, Pleiner T, Görlich D (2015) Crystal structure of the metazoan Nup62•Nup58•Nup54 nucleoporin complex. Science 350:106–110. https://doi.org/10.1126/science.aac7420CrossRefPubMed

40.

Lemke EA (2016) The multiple faces of disordered nucleoporins. J Mol Biol 428:2011–2024. https://doi.org/10.1016/j.jmb.2016.01.002CrossRefPubMedPubMedCentral

41.

Hampoelz B, Andres-Pons A, Kastritis P, Beck M (2019) Structure and assembly of the nuclear pore complex. Annu Rev Biophys 48:515–536. https://doi.org/10.1146/annurev-biophys-052118-115308CrossRefPubMed

42.

Petrovic S, Mobbs GW, Bley CJ, Nie S, Patke A, Hoelz A (2022) Structure and function of the nuclear pore complex. Cold Spring Harb Perspect Biol 14:a041264. https://doi.org/10.1101/cshperspect.a041264CrossRefPubMed

43.

Schwartz TU (2016) The structure inventory of the nuclear pore complex. J Mol Biol 428:1986–2000. https://doi.org/10.1016/j.jmb.2016.03.015CrossRefPubMedPubMedCentral

44.

Kelley K, Knockenhauer KE, Kabachinski G, Schwartz TU (2015) Atomic structure of the Y complex of the nuclear pore. Nat Struct Mol Biol 22:425–431. https://doi.org/10.1038/nsmb.2998CrossRefPubMedPubMedCentral

45.

Vollmer B, Antonin W (2014) The diverse roles of the Nup93/Nic96 complex proteins - structural scaffolds of the nuclear pore complex with additional cellular functions. Biol Chem 395:515–528. https://doi.org/10.1515/hsz-2013-0285CrossRefPubMed

46.

Stuwe T, von Borzyskowski LS, Davenport AM, Hoelz A (2012) Molecular basis for the anchoring of proto-oncoprotein Nup98 to the cytoplasmic face of the nuclear pore complex. J Mol Biol 419:330–346. https://doi.org/10.1016/j.jmb.2012.03.024CrossRefPubMedPubMedCentral

47.

Bley CJ, Nie S, Mobbs GW, Petrovic S, Gres AT, Liu X, Mukherjee S, Harvey S, Huber FM, Lin DH, Brown B, Tang AW, Rundlet EJ, Correia AR, Chen S, Regmi SG, Stevens TA, Jette CA, Dasso M, Patke A, Palazzo AF, Kossiakoff AA, Hoelz A (2022) Architecture of the cytoplasmic face of the nuclear pore. Science 376:eabm9129. https://doi.org/10.1126/science.abm9129CrossRefPubMedPubMedCentral

48.

Li C, Goryaynov A, Yang W (2016) The selective permeability barrier in the nuclear pore complex. Nucleus 7:430–446. https://doi.org/10.1080/19491034.2016.1238997CrossRefPubMedPubMedCentral

49.

Raices M, D’Angelo MA (2017) Nuclear pore complexes and regulation of gene expression. Curr Opin Cell Biol 46:26–32. https://doi.org/10.1016/j.ceb.2016.12.006CrossRefPubMedPubMedCentral

50.

Ibarra A, Hetzer MW (2015) Nuclear pore proteins and the control of genome functions. Genes Dev 29:337–349. https://doi.org/10.1101/gad.256495.114CrossRefPubMedPubMedCentral

51.

Ptak C, Aitchison JD, Wozniak RW (2014) The multifunctional nuclear pore complex: a platform for controlling gene expression. Curr Opin Cell Biol 28:46–53. https://doi.org/10.1016/j.ceb.2014.02.001CrossRefPubMed

52.

Light WH, Freaney J, Sood V, Thompson A, D’Urso A, Horvath CM, Brickner JH (2013) A conserved role for human Nup98 in altering chromatin structure and promoting epigenetic transcriptional memory. PLoS Biol 11:e1001524. https://doi.org/10.1371/journal.pbio.1001524CrossRefPubMedPubMedCentral

53.

Weinberg-Shukron A, Renbaum P, Kalifa R, Zeligson S, Ben-Neriah Z, Dreifuss A, Abu-Rayyan A, Maatuk N, Fardian N, Rekler D, Kanaan M, Samson AO, Levy-Lahad E, Gerlitz O, Zangen D (2015) A mutation in the nucleoporin-107 gene causes XX gonadal dysgenesis. J Clin Invest 125:4295–4304. https://doi.org/10.1172/JCI83553CrossRefPubMedPubMedCentral

54.

Hashizume C, Kobayashi A, Wong RW (2013) Down-modulation of nucleoporin RanBP2/Nup358 impaired chromosomal alignment and induced mitotic catastrophe. Cell Death Dis 4:e854. https://doi.org/10.1038/cddis.2013.370CrossRefPubMedPubMedCentral

55.

Forbes DJ, Travesa A, Nord MS, Bernis C (2015) Nuclear transport factors: global regulation of mitosis. Curr Opin Cell Biol 35:78–90. https://doi.org/10.1016/j.ceb.2015.04.012CrossRefPubMedPubMedCentral

56.

Kuhn TM, Capelson M (2019) Nuclear pore proteins in regulation of chromatin state. Cells 8:1414. https://doi.org/10.3390/cells8111414CrossRefPubMedPubMedCentral

57.

Light WH, Brickner JH (2013) Nuclear pore proteins regulate chromatin structure and transcriptional memory by a conserved mechanism. Nucleus 4:357–360. https://doi.org/10.4161/nucl.26209CrossRefPubMedPubMedCentral

58.

Ptak C, Wozniak RW (2016) Nucleoporins and chromatin metabolism. Curr Opin Cell Biol 40:153–160. https://doi.org/10.1016/j.ceb.2016.03.024CrossRefPubMed

59.

Mishra RK, Chakraborty P, Arnaoutov A, Fontoura BM, Dasso M (2010) The Nup107-160 complex and gamma-TuRC regulate microtubule polymerization at kinetochores. Nat Cell Biol 12:164–169. https://doi.org/10.1038/ncb2016CrossRefPubMedPubMedCentral

60.

Ródenas E, González-Aguilera C, Ayuso C, Askjaer P (2012) Dissection of the NUP107 nuclear pore subcomplex reveals a novel interaction with spindle assembly checkpoint protein MAD1 in Caenorhabditis elegans. Mol Biol Cell 23:930–944. https://doi.org/10.1091/mbc.E11-11-0927CrossRefPubMedPubMedCentral

61.

Dickmanns A, Kehlenbach RH, Fahrenkrog B (2015) Nuclear pore complexes and nucleocytoplasmic transport: from structure to function to disease. Int Rev Cell Mol Biol 320:171–233. https://doi.org/10.1016/bs.ircmb.2015.07.010CrossRefPubMed

62.

Rogg M, Maier JI, Ehle M, Sammarco A, Schilling O, Werner M, Schell C (2022) NUP133 controls nuclear pore assembly, transcriptome composition, and cytoskeleton regulation in podocytes. Cells 11:1259. https://doi.org/10.3390/cells11081259CrossRefPubMedPubMedCentral

63.

Ester L, Cabrita I, Ventzke M, Kieckhöfer E, Christodoulou M, Mandel AM, Diefenhardt P, Fabretti F, Benzing T, Habbig S, Schermer B (2023) The role of the FSGS disease gene product and nuclear pore protein NUP205 in regulating nuclear localization and activity of transcriptional regulators YAP and TAZ. Hum Mol Genet 32:3153–3165. https://doi.org/10.1093/hmg/ddad135CrossRefPubMedPubMedCentral

64.

Gee HY, Saisawat P, Ashraf S, Hurd TW, Vega-Warner V, Fang H, Beck BB, Gribouval O, Zhou W, Diaz KA, Natarajan S, Wiggins RC, Lovric S, Chernin G, Schoeb DS, Ovunc B, Frishberg Y, Soliman NA, Fathy HM, Goebel H, Hoefele J, Weber LT, Innis JW, Faul C, Han Z, Washburn J, Antignac C, Levy S, Otto EA, Hildebrandt F (2013) ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling. J Clin Invest 123:3243–3253. https://doi.org/10.1172/JCI69134CrossRefPubMedPubMedCentral

65.

Gee HY, Sadowski CE, Aggarwal PK, Porath JD, Yakulov TA, Schueler M, Lovric S, Ashraf S, Braun DA, Halbritter J, Fang H, Airik R, Vega-Warner V, Cho KJ, Chan TA, Morris LG, Ffrench-Constant C, Allen N, McNeill H, Buscher R, Kyrieleis H, Wallot M, Gaspert A, Kistler T, Milford DV, Saleem MA, Keng WT, Alexander SI, Valentini RP, Licht C, Teh JC, Bogdanovic R, Koziell A, Bierzynska A, Soliman NA, Otto EA, Lifton RP, Holzman LB, Sibinga NE, Walz G, Tufro A, Hildebrandt F (2016) FAT1 mutations cause a glomerulotubular nephropathy. Nat Commun 7:10822. https://doi.org/10.1038/ncomms10822CrossRefPubMedPubMedCentral

66.

Gee HY, Zhang F, Ashraf S, Kohl S, Sadowski CE, Vega-Warner V, Zhou W, Lovric S, Fang H, Nettleton M, Zhu JY, Hoefele J, Weber LT, Podracka L, Boor A, Fehrenbach H, Innis JW, Washburn J, Levy S, Lifton RP, Otto EA, Han Z, Hildebrandt F (2015) KANK deficiency leads to podocyte dysfunction and nephrotic syndrome. J Clin Invest 125:2375–2384. https://doi.org/10.1172/JCI79504CrossRefPubMedPubMedCentral

67.

Meng XM, Huang XR, Xiao J, Chung AC, Qin W, Chen HY, Lan HY (2012) Disruption of Smad4 impairs TGF-β/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitro. Kidney Int 81:266–279. https://doi.org/10.1038/ki.2011.327CrossRefPubMed

68.

Li J, Sun YBY, Chen W, Fan J, Li S, Qu X, Chen Q, Chen R, Zhu D, Zhang J, Wu Z, Chi H, Crawford S, Oorschot V, Puelles VG, Kerr PG, Ren Y, Nilsson SK, Christian M, Tang H, Chen W, Bertram JF, Nikolic-Paterson DJ, Yu X (2020) Smad4 promotes diabetic nephropathy by modulating glycolysis and OXPHOS. EMBO Rep 21:e48781. https://doi.org/10.15252/embr.201948781CrossRefPubMedPubMedCentral

69.

Schwartzman M, Reginensi A, Wong JS, Basgen JM, Meliambro K, Nicholas SB, D’Agati V, McNeill H, Campbell KN (2016) Podocyte-specific deletion of yes-associated protein causes FSGS and progressive renal failure. J Am Soc Nephrol 27:216–226. https://doi.org/10.1681/asn.2014090916CrossRefPubMed

70.

Chen J, Wang X, He Q, Harris RC (2022) TAZ is important for maintenance of the integrity of podocytes. Am J Physiol Renal Physiol 322:F419–F428. https://doi.org/10.1152/ajprenal.00426.2021CrossRefPubMedPubMedCentral

71.

Hinkes BG, Mucha B, Vlangos CN, Gbadegesin R, Liu J, Hasselbacher K, Hangan D, Ozaltin F, Zenker M, Hildebrandt F (2007) Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2). Pediatrics 119:e907–e919. https://doi.org/10.1542/peds.2006-2164CrossRefPubMed

72.

Taniguchi Y, Nagano C, Sekiguchi K, Tashiro A, Sugawara N, Sakaguchi H, Umeda C, Aoto Y, Ishiko S, Rossanti R, Sakakibara N, Horinouchi T, Yamamura T, Kondo A, Nagai S, Nagase H, Iijima K, Miner JH, Nozu K (2021) Clear evidence of LAMA5 gene biallelic truncating variants causing infantile nephrotic syndrome. Kidney 2:1968–1978. https://doi.org/10.34067/kid.0004952021CrossRef

73.

Hinkes B, Wiggins RC, Gbadegesin R, Vlangos CN, Seelow D, Nurnberg G, Garg P, Verma R, Chaib H, Hoskins BE, Ashraf S, Becker C, Hennies HC, Goyal M, Wharram BL, Schachter AD, Mudumana S, Drummond I, Kerjaschki D, Waldherr R, Dietrich A, Ozaltin F, Bakkaloglu A, Cleper R, Basel-Vanagaite L, Pohl M, Griebel M, Tsygin AN, Soylu A, Muller D, Sorli CS, Bunney TD, Katan M, Liu J, Attanasio M, O’Toole JF, Hasselbacher K, Mucha B, Otto EA, Airik R, Kispert A, Kelley GG, Smrcka AV, Gudermann T, Holzman LB, Nurnberg P, Hildebrandt F (2006) Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat Genet 38:1397–1405. https://doi.org/10.1038/ng1918CrossRefPubMed

74.

Colin E, Huynh Cong E, Mollet G, Guichet A, Gribouval O, Arrondel C, Boyer O, Daniel L, Gubler MC, Ekinci Z, Tsimaratos M, Chabrol B, Boddaert N, Verloes A, Chevrollier A, Gueguen N, Desquiret-Dumas V, Ferre M, Procaccio V, Richard L, Funalot B, Moncla A, Bonneau D, Antignac C (2014) Loss-of-function mutations in WDR73 are responsible for microcephaly and steroid-resistant nephrotic syndrome: Galloway-Mowat syndrome. Am J Hum Genet 95:637–648. https://doi.org/10.1016/j.ajhg.2014.10.011CrossRefPubMedPubMedCentral

75.

Preston R, Stuart HM, Lennon R (2019) Genetic testing in steroid-resistant nephrotic syndrome: why, who, when and how? Pediatr Nephrol 34:195–210. https://doi.org/10.1007/s00467-017-3838-6CrossRefPubMed

76.

Magnasco A, Ravani P, Edefonti A, Murer L, Ghio L, Belingheri M, Benetti E, Murtas C, Messina G, Massella L, Porcellini MG, Montagna M, Regazzi M, Scolari F, Ghiggeri GM (2012) Rituximab in children with resistant idiopathic nephrotic syndrome. J Am Soc Nephrol 23:1117–1124. https://doi.org/10.1681/asn.2011080775CrossRefPubMedPubMedCentral

Title: Nucleoporin-associated steroid-resistant nephrotic syndrome
Authors: Ling Yao
Yuanyuan Li
Ping Wang
Chan Xu
Zihua Yu
Publication date: 27-09-2024
Publisher: Springer Berlin Heidelberg
Keywords: Nephrotic Syndrome
Peritoneal Dialysis
Published in: Pediatric Nephrology
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-024-06494-3

Keynote webinar | Spotlight on modern management of frailty

Springer Medicine

Nucleoporin-associated steroid-resistant nephrotic syndrome

Abstract

Keynote webinar | Spotlight on modern management of frailty

Springer Medicine

Abstract

Please log in to get access to this content